Mobilicom CEO Oren Elkayam to Participate in Fireside Chat at the “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era” Conference, presented by Maxim Group LLC, on June 5, 2024
June 03, 2024 07:10 ET
|
Mobilicom Limited
Shoham, Israel, June 03, 2024 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB, MOBBW), a provider of cybersecurity and robust solutions for drones and robotics, today announced its CEO and...
uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease
June 03, 2024 07:05 ET
|
uniQure Inc.
~ Designation based on 24-month interim Phase I/II clinical data for AMT-130 announced in December 2023 ~ ~ AMT-130 is the first therapeutic candidate to receive RMAT Designation for Huntington’s...
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
June 03, 2024 07:01 ET
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate...
Fortrea to Present at the Jefferies Global Healthcare Conference
June 03, 2024 07:00 ET
|
Fortrea Holdings Inc
DURHAM, N.C., June 03, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and...
Smart Share Global Limited Announces First Quarter 2024 Results
June 03, 2024 07:00 ET
|
Smart Share Global Limited
POIs1 operated through network partner model reached 79.7% as of the end of the first quarter of 2024Cumulative registered users2 reached 404.3 million as of the end of the first quarter of 2024 ...
NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with COVIRIX
June 03, 2024 07:00 ET
|
NewGenIVF Limited
BANGKOK, Thailand, June 03, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals...
Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)
June 03, 2024 07:00 ET
|
Beyond Air™
– Ongoing Phase 1a first-in-human clinical trial continues to demonstrate proof of concept for the UNO solid tumor platform with observed early tumor responses and clinical resolution of radiation...
Skye Bioscience to Present at Jefferies Global Healthcare Conference
June 03, 2024 07:00 ET
|
Skye Bioscience, Inc.
SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...
Colliers to Acquire Leading Canadian Engineering Firm Englobe
June 03, 2024 07:00 ET
|
Colliers International Group Inc
TORONTO and LAVAL, June 03, 2024 (GLOBE NEWSWIRE) -- Global diversified professional services and investment management company, Colliers (NASDAQ, TSX: CIGI), announced today it has entered into a...
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting
June 03, 2024 07:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to...